These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21667035)

  • 1. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
    Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the T1/2N1 (≤3 nodes) category actually stage IIIA (TNM)/IIIa (Japanese classification) in patients with primary colorectal cancer?
    Mukai M; Kishima K; Fukumitsu H; Sekido Y; Izumi H; Hoshikawa T; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Jul; 26(1):209-14. PubMed ID: 21519799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
    Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
    Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
    Kim KH; Yang SS; Yoon YS; Lim SB; Yu CS; Kim JC
    Colorectal Dis; 2011 Aug; 13(8):e220-6. PubMed ID: 21689314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.
    Segelman J; Singnomklao T; Hellborg H; Martling A
    Colorectal Dis; 2009 Sep; 11(7):768-74. PubMed ID: 18662241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hand-assisted laparoscopic colon and rectal cancer surgery: feasibility, short-term, and oncological outcomes.
    Pendlimari R; Holubar SD; Pattan-Arun J; Larson DW; Dozois EJ; Pemberton JH; Cima RR
    Surgery; 2010 Aug; 148(2):378-85. PubMed ID: 20633732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer.
    Kobayashi H; Ueno H; Hashiguchi Y; Mochizuki H
    Surgery; 2006 Apr; 139(4):516-22. PubMed ID: 16627061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
    Fietkau R; Zettl H; Klöcking S; Kundt G
    Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival in colorectal cancer patients.
    Laohavinij S; Maneechavakajorn J; Techatanol P
    J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.
    Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Nakamura M; Makuuchi H
    Oncol Rep; 2008 Dec; 20(6):1521-6. PubMed ID: 19020736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
    Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.